Home » Topics » BioWorld Science

BioWorld Science
RSS

Oncolytic viruses target GSCs with specific p53 deregulations for personalized glioblastoma therapy

Sep. 23, 2021

Inhaled antibodies brought to SARS-CoV fight

Sep. 22, 2021

Synthetic queuine STL-101 shows neuroprotective potential

Sep. 22, 2021

Mosaic licenses rights to novel vaccine candidates from UC San Diego

Sep. 22, 2021

Novel OSBPL7-targeting compounds show therapeutic efficacy in models of renal disease

Sep. 22, 2021

SNP in the CBS gene tied to overall survival in patients with NSCLC

Sep. 22, 2021

Theragnostics and AAA to jointly develop Ga-68 one-step PET radiopharmaceuticals

Sep. 22, 2021

CMTA and Addex collaborate to investigate GABA-B PAMs for CMT1A

Sep. 22, 2021

Clearmind and Hebrew University partner on novel psychedelics

Sep. 22, 2021

Seneca launches cancer gene delivery platform based on SVV-001 technology

Sep. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.